ArticleAdvanced pharmaceutical bulletin2022

High Sensitivity Troponin T as Complementary Modality for Determining Doxorubicin Regimen Cardiotoxicity in Non-Hodgkin Lymphoma Patients.

Ami Ashariati Prayogo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.